NCT06465147View on ClinicalTrials.gov

REACT-01: Reversing Autoimmunity Through Cell Therapy

PHASE1RecruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2041

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL

SCRI-CAR19v3

Single infusion of SCRI-CAR19v3

Trial Locations (1)

98105

RECRUITING

Seattle Children's Hospital, Seattle

All Listed Sponsors

lead

Seattle Children's Hospital

OTHER